MedTrace Logo

Cognitive Assessment Tools for Huntington's Disease.

NCT06546488 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2026-03-02

No results posted yet for this study

Summary

The purpose of the current proposal is to expand understanding of two currently available cognitive tools that are not typically used in Huntington Disease (HD) clinical trials that might be useful both for initial screening and for clinical trial application. One is the Coding Test and the other is the Self-Administered Gerocognitive Examination (SAGE). Both the Coding Test and the SAGE have been used for assessments of individuals with other neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease and Lewy Body Disease, but data is lacking on their use in individuals with HD.

Conditions

  • Huntington Disease

Interventions

BEHAVIORAL

Assessments

A standardized assessment battery will be administered. It will consist of cognitive, functional and motor assessments.

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2027-12-01
Completion
2027-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546488 on ClinicalTrials.gov